Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients

Innovative Uses of Rituximab in Dermatology

(2010) David R. Carr et al.   DERMATOLOGIC CLINICS

Therapeutic ladder for pemphigus vulgaris: Emphasis on achieving complete remission

(2010) Lindsay C. Strowd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease

(2010) Yaohan Li et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Rituximab in Severe Pemphigus

(2009) Enno Schmidt et al.   Annals of the New York Academy of Sciences

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

(2008) Michael Hertl et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: A paradigm of human autoimmunity

(2008) Donna A. Culton et al.   JOURNAL OF AUTOIMMUNITY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY